Dana-Farber Cancer Institute, Site 008
Boston, Massachusetts 02215
We've found
1 trials
at this facility
Chronic Myeloid Leukemia Clinical Trial
Updated: 9/26/2013
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Status: Enrolling
Updated: 9/26/2013
Click here to add this to my saved trials